Marc Nasoff

1.7k total citations
34 papers, 1.4k citations indexed

About

Marc Nasoff is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Marc Nasoff has authored 34 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 12 papers in Radiology, Nuclear Medicine and Imaging and 11 papers in Immunology. Recurrent topics in Marc Nasoff's work include Monoclonal and Polyclonal Antibodies Research (11 papers), Immunotherapy and Immune Responses (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Marc Nasoff is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (11 papers), Immunotherapy and Immune Responses (6 papers) and Glycosylation and Glycoproteins Research (5 papers). Marc Nasoff collaborates with scholars based in United States, China and Japan. Marc Nasoff's co-authors include Geneviève Inchauspé, S L Zebedee, Quinn L. Deveraux, Deborah Knee, Masahiko Sugitani, A. M. Prince, Kim Quon, A. M. Prince, Richard E. Wolf and Xin Du and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Clinical Oncology.

In The Last Decade

Marc Nasoff

34 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Marc Nasoff United States	16	638	441	350	211	198	34	1.4k
G Abelev Russia	16	904 1.4×	371 0.8×	384 1.1×	177 0.8×	108 0.5×	59	2.3k
Joachim Lupberger France	19	484 0.8×	582 1.3×	626 1.8×	55 0.3×	111 0.6×	37	1.4k
Frank Hensel Germany	22	658 1.0×	505 1.1×	620 1.8×	383 1.8×	73 0.4×	40	1.6k
Urania Georgopoulou Greece	18	397 0.6×	441 1.0×	435 1.2×	56 0.3×	64 0.3×	55	1.0k
Nadine Weich United States	15	806 1.3×	170 0.4×	396 1.1×	23 0.1×	258 1.3×	23	1.7k
Peter J. Welch United States	18	1.1k 1.7×	113 0.3×	126 0.4×	75 0.4×	170 0.9×	24	1.7k
Teruaki Sekine Japan	14	442 0.7×	352 0.8×	262 0.7×	96 0.5×	74 0.4×	44	1.5k
Benjamin T. Vroman United States	20	1.1k 1.7×	230 0.5×	207 0.6×	62 0.3×	48 0.2×	24	1.8k
Abdel‐Rahman N. Zekri Egypt	29	1.0k 1.6×	792 1.8×	832 2.4×	76 0.4×	23 0.1×	159	2.7k
Keiko Miyano Japan	8	631 1.0×	544 1.2×	492 1.4×	100 0.5×	34 0.2×	11	1.5k

Countries citing papers authored by Marc Nasoff

Since Specialization

Citations

This map shows the geographic impact of Marc Nasoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc Nasoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc Nasoff more than expected).

Fields of papers citing papers by Marc Nasoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc Nasoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc Nasoff. The network helps show where Marc Nasoff may publish in the future.

Co-authorship network of co-authors of Marc Nasoff

This figure shows the co-authorship network connecting the top 25 collaborators of Marc Nasoff. A scholar is included among the top collaborators of Marc Nasoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marc Nasoff. Marc Nasoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Aggarwal, Rahul, Jacqueline Vuky, David James VanderWeele, et al.. (2025). Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer. Journal of Clinical Oncology. 43(15). 1824–1834. 5 indexed citations

Budimir, Natalija, Simon Shenhav, Hua Wu, et al.. (2022). 1325 Preclinical activity and safety profile of JANX007, a novel PSMA-targeting tumor-activated T Cell engager for treatment of metastatic castration-resistant prostate cancer. Regular and Young Investigator Award Abstracts. A1376–A1376. 7 indexed citations

Budimir, Natalija, Lina Ma, Simon Shenhav, et al.. (2022). 1123 Preclinical activity and safety profile or JANX008, a novel EGFR-targeting tumor-activated T cell engager for treatment of solid tumors. Regular and Young Investigator Award Abstracts. A1167–A1167. 3 indexed citations

Wong, Sandy W., Philip Imus, Tomer M. Mark, et al.. (2021). P-225: A first-in-human study of FOR46 in patients with triple refractory Multiple Myeloma. Clinical Lymphoma Myeloma & Leukemia. 21. S164–S164. 8 indexed citations

Kautz, Léon, Grace Jung, Xin Du, et al.. (2015). Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of β-thalassemia. Blood. 126(17). 2031–2037. 227 indexed citations

Rue, Sarah, Brendan P. Eckelman, Jem Efe, et al.. (2015). Identification of a candidate therapeutic antibody for treatment of canine B-cell lymphoma. Veterinary Immunology and Immunopathology. 164(3-4). 148–159. 43 indexed citations

Lau, Janet, Deborah Knee, Christophe Filippi, et al.. (2013). IL-2 Immunotherapy Reveals Potential for Innate Beta Cell Regeneration in the Non-Obese Diabetic Mouse Model of Autoimmune Diabetes. PLoS ONE. 8(10). e78483–e78483. 14 indexed citations

Li, Jing, Qingxiu Zhang, Jennifer Johnson, et al.. (2007). Tumor-cell specific cytotoxic activity of LBY135, a novel anti- DR5 agonistic antibody. Cancer Research. 67. 4875–4875. 3 indexed citations

Li, Jing, Betty Tang, Joseph Eckman, et al.. (2007). Antitumor efficacy of LBY135, an anti-DR5 monoclonal antibody, alone or in combination with chemotherapy in human colon tumor cell lines and xenografts. Cancer Research. 67. 4874–4874. 5 indexed citations

10.

Gaskins, C. T., et al.. (2005). Generation of a Monoclonal Antibody Agonist to Toll-Like Receptor 4. Hybridoma. 24(1). 27–35. 4 indexed citations

11.

Rottmann, Sabine, Yan Wang, Marc Nasoff, Quinn L. Deveraux, & Kim Quon. (2005). A TRAIL receptor-dependent synthetic lethal relationship between MYC activation and GSK3β/FBW7 loss of function. Proceedings of the National Academy of Sciences. 102(42). 15195–15200. 86 indexed citations

12.

Wang, Yan, Ingo H. Engels, Deborah Knee, et al.. (2004). Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway. Cancer Cell. 5(5). 501–512. 131 indexed citations

13.

Wagner, Klaus W., et al.. (2004). Differential Regulation of the TRAIL Death Receptors DR4 and DR5 by the Signal Recognition Particle. Molecular Biology of the Cell. 15(11). 5064–5074. 92 indexed citations

14.

Wagner, Klaus W., et al.. (2003). Activation and Suppression of the TRAIL Death-Receptor Pathway in Chemotherapy Sensitive and Resistant Follicular Lymphoma Cells. Cancer Biology & Therapy. 2(5). 534–540. 8 indexed citations

15.

Nasoff, Marc, et al.. (2000). [31] High-throughput expression of fusion proteins. Methods in enzymology on CD-ROM/Methods in enzymology. 328. 515–529. 9 indexed citations

16.

Koda, Keiji, Norihiko Saito, Noboru Nakajima, et al.. (2000). Identification of the immunoreactive peptide sequence for AgSK1, an adenocarcinoma‐restricted antigen. Tissue Antigens. 55(2). 157–161. 1 indexed citations

17.

Nasoff, Marc, et al.. (1997). Cloning and Expression of the Human Tumor-Specific Antibody GM4. Hybridoma. 16(5). 427–439. 4 indexed citations

18.

Prince, A. M., Betsy Brotman, Geneviève Inchauspé, et al.. (1993). Patterns and Prevalence of Hepatitis C Virus Infection in Posttransfusion Non-A, Non-B Hepatitis. The Journal of Infectious Diseases. 167(6). 1296–1301. 26 indexed citations

19.

Nasoff, Marc, S L Zebedee, Geneviève Inchauspé, & A. M. Prince. (1991). Identification of an immunodominant epitope within the capsid protein of hepatitis C virus.. Proceedings of the National Academy of Sciences. 88(12). 5462–5466. 111 indexed citations

20.

Nasoff, Marc, Henry V. Baker, & Richard E. Wolf. (1984). DNA sequence of the Escherichia coli gene, gnd, for 6-phosphogluconate dehydrogenase. Gene. 27(3). 253–264. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact